Neurochlore
Neurochlore is a pioneering startup founded in 2012 by Prof. Y. BEN-ARI, dedicated to studying the fundamental mechanisms of the brain. The company utilizes unique concepts like Neuroarchaeology and GABAergic Polarity to understand the excitation/inhibition balance crucial for brain development. Disruptions in this balance are linked to neurodevelopmental disorders such as autism, as well as brain tumors. Neurochlore supports two startups: B&A Oncomedical, developing a combined anti-cancer molecule approach for brain tumors, and B&A Biomedical, using AI for healthcare and biology data analysis. Neurochlore's research focuses on neurodevelopment, neuro-archeology, pregnancy, and the role of Bumetanide and GABA polarity, with projects including identifying Bumetanide responders for autism spectrum disorders, developing therapeutic approaches for brain tumors, and creating new NKCC1 inhibitors.
Neurochlore
Neurochlore is a pioneering startup founded in 2012 by Prof. Y. BEN-ARI, dedicated to studying the fundamental mechanisms of the brain. The company utilizes unique concepts like Neuroarchaeology and GABAergic Polarity to understand the excitation/inhibition balance crucial for brain development. Disruptions in this balance are linked to neurodevelopmental disorders such as autism, as well as brain tumors. Neurochlore supports two startups: B&A Oncomedical, developing a combined anti-cancer molecule approach for brain tumors, and B&A Biomedical, using AI for healthcare and biology data analysis. Neurochlore's research focuses on neurodevelopment, neuro-archeology, pregnancy, and the role of Bumetanide and GABA polarity, with projects including identifying Bumetanide responders for autism spectrum disorders, developing therapeutic approaches for brain tumors, and creating new NKCC1 inhibitors.